• The research at the Institute of Radiation Biology (ISB) focuses on the health challenges posed by the chronic diseases that develop in long-term survivors of cancer radiotherapy. Our goal is to minimise the pathophysiology, in particular in tissues at the periphery of the radiation field receiving low radiation doses. The research groups examine the physiological effects of low doses of radiation in the brain, heart and lung tissue, in stem cells and in endothelial cells. We are developing pharmacological strategies to lower radiation doses and to ameliorate damage, and we investigate the influence of genetic and epigenetic regulation in determining the response of individual patients. The ISB is a part of the Department of Radiation Sciences (DRS).

We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player or Twitter feeds. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.